Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $18.57 (+1.59%), Market cap $3.80B, P/E ratio 32.22, 52-week low–high $7.16 ~ $15.19.
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. The Specialty segment develops, promotes, sells, and di
Financial statements, price targets, institutional (13F) holdings and related news for Amneal Pharmaceuticals, Inc. Class A Common Stock are updated in real time on BlackAll Trade.
Amneal Pharmaceuticals, Inc. Class A Common Stock trades at $18.57 (+1.59%). Real-time quotes and charts are available on BlackAll Trade.
Amneal Pharmaceuticals, Inc. Class A Common Stock has a market cap of about $3.80B. Its P/E ratio is 32.22.
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in